SCHEMBL29201264

SCHEMBL29201264

CC(C)(C)OC(=O)N1CCC(=C=O)C(C)(F)C1

nearest known ligand 0.40

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 2/20 0.40
USP2 O75604 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ESR2 Q92731 1/20 0.39
ADORA1 P30542 1/20 0.36
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
DDB1 Q16531 2/20 0.35
CRBN Q96SW2 2/20 0.35
RORC P51449 6/20 0.35
GRM5 P41594 2/20 0.35
HDAC2 Q92769 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29286890 0.90 USP2 (0.41) NR1H2USP2SMN1; SMN2ESR2ADORA1
SCHEMBL27660306 0.87 NR1H2 (0.44) NR1H2USP2SMN1; SMN2ESR2ADORA1
SCHEMBL15749495 0.81 NR1H2 (0.43) NR1H2USP2SMN1; SMN2ESR2ADORA1
SCHEMBL30075744 0.81 NR1H2 (0.43) NR1H2USP2SMN1; SMN2ESR2ADORA1
SCHEMBL518157 0.74 USP2 (0.42) NR1H2USP2SMN1; SMN2ESR2ADORA1
SCHEMBL21098079 0.73 USP2 (0.47) NR1H2USP2SMN1; SMN2ALDH1A1LMNA
Water SCHEMBL26621617 0.72 USP2 (0.41) NR1H2USP2SMN1; SMN2ESR2ADORA1
SCHEMBL29440339 0.72 USP2 (0.41) NR1H2USP2SMN1; SMN2ESR2ADORA1
SCHEMBL14795217 0.72 USP2 (0.51) NR1H2USP2SMN1; SMN2ESR2ADORA1
SCHEMBL517374 0.72 NR1H2 (0.46) NR1H2USP2SMN1; SMN2ESR2ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4393916-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Hansoh Biomedical Co., Ltd. (CN) 2024-07-03 EP disclosed
CN-117813299-A Nitrogen-containing heterocyclic derivative inhibitor, preparation method and application thereof 上海翰森生物医药科技有限公司 2024-04-02 CN disclosed